Home
/
Glossary
/
Genotoxic Impurity Control
General Biopharmaceutical Concepts

Genotoxic Impurity Control

Genotoxic impurity control identifies, monitors and limits DNA-reactive impurities to minimise mutagenic risk and ensure regulatory compliance.

Genotoxic impurity control establishes procedures preventing mutagenic contaminant introduction or accumulation. Process chemistry design minimises impurity generation at source. Purification methods remove genotoxic species. Analytical surveillance detects emerging genotoxic impurities. Risk-based approaches prioritise highest-concern impurities.

Regulatory thresholds establish acceptable genotoxic impurity limits. Structural alerts predict genotoxicity hazards. Toxicology testing confirms impurity acceptability. Manufacturing controls prevent exceeding thresholds. Post-approval monitoring ensures ongoing compliance.

📘 Explore the Glossary

✓ 903 Definitions

✓ 18 Categories

✓ Updated Weekly

Continue Exploring

Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.

Browse Glossary →
WhatsApp